Dr. Michael Anthony Sanchez, MD

Dr. Sanchez practices at Facey Endoscopy Center in Mission Hills, California.

Dr. Sanchez's NPI, 1174539100, was assigned on July 31, 2006. Dr. Sanchez graduated from David Geffen School of Medicine at UCLA in 1990. Dr. Sanchez holds California license G73436.

Dr. Sanchez's primary practice is Facey Endoscopy Center, at 11333 Sepulveda Blvd, #3200, Mission Hills, CA 91345. The practice phone is (818) 837-5776.

Dr. Sanchez's primary practice is Facey Endoscopy Center in Mission Hills, California. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Sanchez to 1 more home health agency, named with a free account. Dr. Sanchez's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sanchez practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sanchez's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sanchez is board certified in internal medicine by the American Board of Internal Medicine. Dr. Sanchez is licensed in California.

Dmand AI lists acute sinusitis, aneurysm, asthma, chronic diabetes, chronic hypertension, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and diabetic emergency among the conditions Dr. Sanchez treats.

CMS data shows 296 Medicare services from Dr. Sanchez across 4 procedure codes in 2024, for 102 Medicare patients. Medicare paid $14,058 for them. Every service was in an office.

CMS counts 102 Medicare patients who saw Dr. Sanchez in 2024. The largest group is 65 to 74, with 42 patients. 71% of them have high blood pressure, and 70% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sanchez's median patient age at 72, with 51% women.

In 2024, Dr. Sanchez wrote 10,975 Medicare Part D claims for 824 patients. 89% of them were for generic drugs. CMS names the drug for 10,144 of them, across 128 drugs with 11 or more claims each, at $653,344 in total drug cost. In 2023, CMS named 9,365 claims across 122 drugs.

Dr. Sanchez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sanchez as offering telehealth.

Dmand AI links 1 paper to Dr. Sanchez in 2015. Dr. Sanchez's most frequent co-authors are Daniel Clark Files, MD and Peter Eugene Morris, MD.

Dmand AI links Dr. Sanchez to 1 clinical trial. Conditions studied include Critical Illness and Disease Attributes.

CMS Open Payments shows 152 general payments to Dr. Sanchez from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $589.

Dmand AI lists 1 award for Dr. Sanchez, most recently CMS Stage 1 2012 in 2012.

Dr. Sanchez graduated from David Geffen School of Medicine at UCLA in 1990.

Dr. Sanchez is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.